MENU
CGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cognition Therapeutics (CGTX) Ownership - Who owns Cognition Therapeutics?

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina... Show more

Profile

Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
14
Web
https://www.cogrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
150.36M
P/E Ratio
N/A
Total Cash
31.13M
Projected Growth
N/A
Total Debt
465K
Revenue
N/A
Risk (Beta)
1.39
Dividend Yield
N/A
Total Cash/Share
0.35
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
CGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
14
Web
https://www.cogrx.com